Microbio Co., Ltd.
- Jurisdiction
Taiwan - ISIN
TW0004128004 (4128.TWO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. Read full profile
Stock price
Fundamentals
- Net revenue
€50.89M - Gross margin
39.4% - EBIT
-€11.54M - EBIT margin
-22.7% - Net income
-€37.61M - Net margin
-73.9%
Statement period: - (published )
Dividends
- Last dividend amount
-
NT$0.05 - Ex date
-
- Payment date
-